Bio-Thera Solutions,Ltd. Financials

Market Capitalization CN¥11.23 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE
Forward PE	-77.46
Price to Sales TTM	CN¥14.24
Price to Book MRQ	CN¥18.26
Enterprise to Revenue	13.42
Enterprise to EBITDA	-24.49

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-61.50%
Operating Margin	-45.91%
Return on Assets TTM	-14.05%
Return on Equity TTM	-56.74%

Income Statement

Revenue TTM	CN¥788,129,728
Revenue per Share TTM	CN¥1.91
Quarterly Revenue Growth	27.80%
Gross Profit TTM	CN¥559,527,936
EBITDA	CN¥-431,979,008
Net Income to Common TTM	CN¥-484,676,736
Diluted EPS TTM	CN¥-1.18
Quarterly Earnings Growth YoY	27.83%

Balance Sheet

Total Cash MRQ	CN¥498,784,448
Total Cash per Share MRQ	CN¥1.21
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	114.15
Current Ratio MRQ	0.86
Book Value per Share MRQ	CN¥1.49

Cash Flow

Operating Cash Flow TTM	CN¥88,566,784
Levered Free Cash Flow TTM	CN¥59,759,308

688177 Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	414,080,000
Float Shares	153,279,994
Avg 10 Volume	3,519,875
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	73.12%
% Held by Institutions	8.85%

Stock Price Summary

Beta	0.42
Fifty Two Week Low	CN¥17.70
Fifty Two Week High	CN¥30.38
Fifty Two Week Change	25.78%
Day 50 MA	CN¥24.30
Day 200 MA	CN¥21.86

Dividends and Splits

Forward Annual Dividend Rate	CN¥
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CN¥0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date